Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 3, 2018
Sun Pharmaceuticals' promoter Dilip Shanghvi denied allegations of insider trading and poor corporate governance after a report that the market regulator may reopen its probe against India’s largest drugmaker and some of its promoters for various lapses.